Giovanni Muto

The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

Complications Following Radical Cystectomy for Bladder Cancer in the Elderly

The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice

Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial

Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases

A microRNA code for prostate cancer metastasis

BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial–mesenchymal transition

Multifunctional Core–Shell Nanoparticles: Discovery of Previously Invisible Biomarkers

SEMINAL SPARING CYSTECTOMY AND ILEOCAPSULOPLASTY: LONG-TERM FOLLOWUP RESULTS

Stage‐specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy

Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer